SynthesisWorld journal of surgical oncology2026
Pulmonary metastasectomy and survival in osteosarcoma: a systematic review and meta-analysis of surgery-related prognostic factors.
Synthesis in World journal of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary metastasis is a major cause of disease progression and mortality in patients with osteosarcoma. The survival impact of pulmonary metastasectomy and the prognostic relevance of surgery-related factors remain incompletely defined. This systematic review and meta-analysis aimed to evaluate the association between pulmonary metastasectomy and survival outcomes and to identify key prognostic determinants.
methodsPubMed, Embase, Web of Science, and the Cochrane Library were systematically searched from inception to December 2025. Studies enrolling patients with histologically confirmed osteosarcoma and lung metastases that examined associations between surgery-related factors and survival outcomes were eligible. Outcomes included post-relapse survival (PRS) and post-metastasectomy overall survival (PMOS). Hazard ratios (HRs) with 95% confidence intervals (CIs) were pooled using fixed- or random-effects models according to between-study heterogeneity.
resultsTwenty-one retrospective studies were included. Pulmonary metastasectomy was associated with improved post-relapse survival compared with no metastasectomy (HR = 0.29, 95% CI: 0.18–0.46). Complete resection consistently demonstrated a favorable association with survival across endpoints (PRS: HR = 0.21, 95% CI: 0.12–0.38; PMOS: HR = 0.31, 95% CI: 0.23–0.42). Bilateral pulmonary metastases were associated with inferior PMOS (HR = 1.56, 95% CI: 1.27–1.93), whereas the association with PRS did not reach statistical significance (HR = 1.37, 95% CI: 0.92–2.04). Video-assisted thoracoscopic surgery was associated with a modestly increased risk of mortality (HR = 1.69, 95% CI: 1.01–2.82). Across studies, a higher number of metastatic nodules was consistently linked to worse survival, although quantitative synthesis was limited by heterogeneous cutoff definitions.
conclusionIn observational studies, pulmonary metastasectomy is associated with improved survival in selected patients with osteosarcoma lung metastases, particularly when complete resection is achieved. Metastatic distribution, nodule burden, and surgical approach may influence prognosis. These findings support careful patient selection and individualized surgical decision-making while underscoring the need for prospective validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.